We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.21%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$61.5B
AUM Growth
+$1.63B
(+2.7%)
Cap. Flow
+$3.27B
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
15.82%
Holding
2,192
New
128
Increased
942
Reduced
851
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$516M |
| 2 |
American Tower
AMT
|
+$389M |
| 3 |
Paychex
PAYX
|
+$344M |
| 4 |
UnitedHealth
UNH
|
+$305M |
| 5 |
Gartner
IT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$475M |
| 2 |
ExxonMobil
XOM
|
+$428M |
| 3 |
American Electric Power
AEP
|
+$289M |
| 4 |
Gilead Sciences
GILD
|
+$257M |
| 5 |
Amgen
AMGN
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.49% |
| 2 | Healthcare | 14.06% |
| 3 | Industrials | 11.95% |
| 4 | Financials | 11.87% |
| 5 | Consumer Discretionary | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Health Catalyst
HCAT
$158M
| $4.48K | ﹤0.01% |
3,527
| – | – |
|
|
RAPP
1902
Rapport Therapeutics
RAPP
$1.97B
| $4.47K | ﹤0.01% |
143
+88
| +160% | +$2.48K |
|
1903
Upbound Group
UPBD
$1.23B
| $4.46K | ﹤0.01% |
247
-732
| -75% | -$14.3K |
|
1904
MediaAlpha
MAX
$751M
| $4.39K | ﹤0.01% |
472
-851
| -64% | -$8.39K |
|
1905
TScan Therapeutics
TCRX
$48.1M
| $4.34K | ﹤0.01% |
4,295
-694
| -14% | -$742 |
|
1906
SunPower Inc
SPWR
$57.7M
| $4.32K | ﹤0.01% |
+3,404
| New | +$5.12K |
|
1907
Mitek Systems
MITK
$750M
| $4.24K | ﹤0.01% |
314
| – | – |
|
1908
Annexon
ANNX
$793M
| $4.17K | ﹤0.01% |
753
| – | – |
|
1909
Weis Markets
WMK
$1.93B
| $4.17K | ﹤0.01% |
61
+33
| +118% | +$2.26K |
|
1910
Allient
ALNT
$1.34B
| $4.14K | ﹤0.01% |
+70
| New | +$4.41K |
|
1911
Cogent Communications
CCOI
$596M
| $4.09K | ﹤0.01% |
217
-19,596
| -99% | -$432K |
|
|
AARD
1912
Aardvark Therapeutics
AARD
$130M
| $4.08K | ﹤0.01% |
+1,083
| New | +$11.2K |
|
1913
Sagimet Biosciences
SGMT
$434M
| $4.08K | ﹤0.01% |
781
+519
| +198% | +$2.89K |
|
1914
Quantum Corp
QMCO
$441M
| $3.97K | ﹤0.01% |
835
+334
| +67% | +$2.02K |
|
|
DFTX
1915
Definium Therapeutics
DFTX
$5.55B
| $3.91K | ﹤0.01% |
207
+140
| +209% | +$2.38K |
|
1916
FuboTV Inc
FUBO
$258M
| $3.85K | ﹤0.01% |
+407
| New | +$8.06K |
|
1917
QuantumScape Corp
QS
$3.11B
| $3.82K | ﹤0.01% |
599
-106
| -15% | -$881 |
|
1918
Universal Electronics
UEIC
$58.5M
| $3.81K | ﹤0.01% |
926
| – | – |
|
1919
Crexendo
CXDO
$218M
| $3.8K | ﹤0.01% |
616
+122
| +25% | +$801 |
|
1920
Gevo
GEVO
$348M
| $3.75K | ﹤0.01% |
+1,372
| New | +$2.84K |
|
1921
Cardiff Oncology
CRDF
$60.7M
| $3.65K | ﹤0.01% |
+2,253
| New | +$4.63K |
|
1922
Velocity Financial
VEL
$697M
| $3.64K | ﹤0.01% |
201
+142
| +241% | +$2.68K |
|
1923
Fate Therapeutics
FATE
$266M
| $3.62K | ﹤0.01% |
3,015
| – | – |
|
1924
Smart Sand
SND
$179M
| $3.59K | ﹤0.01% |
+702
| New | +$3.16K |
|
1925
SandRidge Energy
SD
$502M
| $3.56K | ﹤0.01% |
218
+154
| +241% | +$2.5K |
|
Similar funds
Federated Hermes's Q1 2026 Portfolio in Review
As of Q1 2026, Federated Hermes held 2,192 positions worth $61.5B, up 2.7% from $59.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes deployed $3.27B of net new capital in Q1 2026, opening 128 new positions and adding to 942 existing holdings. Its largest new stake was EquipmentShare.com Inc: 1,549,176 shares worth $31.6M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $475M trimmed.
- Federated Hermes's largest Q1 2026 buy was EquipmentShare.com Inc: 1,549,176 shares worth $31.6M.
- Federated Hermes added most to lululemon athletica in Q1 2026, an estimated $516M increase.
- Federated Hermes's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $475M.
- Federated Hermes fully exited CyberArk in Q1 2026, selling an estimated $81.2M.
- Federated Hermes's ten largest holdings make up 16% of its $61.5B portfolio in Q1 2026.
- Federated Hermes opened 128 new positions and closed 143 in Q1 2026.
- Federated Hermes's portfolio value rose 2.7% quarter-over-quarter to $61.5B.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.